Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Pathogenic oral and intestinal bacteria" is a general term encompassing numerous **disease-associated bacterial species** that colonize the human oral cavity and intestinal tract. Key oral pathogens include *Fusobacterium nucleatum*, *Porphyromonas gingivalis*, *Aggregatibacter actinomycetemcomitans*, *Treponema denticola*, *Streptococcus mutans*, and others, while notable intestinal pathogens overlap with oral ones and may include *Enterobacteriaceae*, *Bacteroides*, and *Clostridium* species[1][2][3]. These bacteria contribute to local diseases such as dental caries, periodontitis, and gastrointestinal infections, but also systemic conditions including inflammatory bowel disease, colorectal and gastric cancers, cardiovascular and neurodegenerative diseases[1][2][3]. They are targets for antimicrobial therapy as a functional group, but the term does not denote a single, well-defined molecular drug target or receptor. For structured drug target data, refer to individual species, their surface proteins, or specific virulence factors rather than this nonspecific grouping.
Disruption of bacterial cell wall or membrane integrity (as with beta-lactams, chlorhexidine) Inhibition of protein, DNA, or metabolic pathways (antibiotics) Bacterial population modulation (e.g., probiotics) Lytic activity (bacteriophages)
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pathogenic oral and intestinal bacterium (null).